MedPath

CUBIST PHARMACEUTICALS LLC

CUBIST PHARMACEUTICALS LLC logo
🇺🇸United States
Ownership
Holding
Established
1992-01-01
Employees
5K
Market Cap
-
Website
http://www.cubist.com

Clinical Trials

13

Active:8
Completed:3

Trial Phases

4 Phases

Phase 1:6
Phase 3:1
Phase 4:2
+1 more phases

Drug Approvals

7

NMPA:3
CANADA:2

Drug Approvals

Daptomycin for Injection

Product Name
克必信
Approval Number
国药准字HJ20181068
Approval Date
Nov 29, 2024
NMPA

Daptomycin for Injection

Product Name
克必信
Approval Number
H20181040
Approval Date
May 20, 2020
NMPA

Daptomycin for Injection

Product Name
克必信
Approval Number
H20181068
Approval Date
May 20, 2020
NMPA

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Phase 1
6 (54.5%)
Not Applicable
2 (18.2%)
Phase 4
2 (18.2%)
Phase 3
1 (9.1%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.